A novel antimicrobial peptide S24 combats serious wound infections caused by Pseudomonas aeruginosa and Acinetobacter baumannii
Journal of Antimicrobial Chemotherapy · 2024
DOI: 10.1093/jac/dkae191 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Meng-Yue Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Pseudomonas aeruginosa, Wound Infection, Acinetobacter Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Science & Technology Fundamental Resources Investigation Program, Liao Ning Revitalization Talents Program, Basic Scientific Research Project of Colleges and University of Liaoning Provincial Department of Education.
Abstract (Originalsprache)
Objectives
Pseudomonas aeruginosa and Acinetobacter baumannii are ranked as top-priority organisms by WHO. Antimicrobial peptides (AMPs) are promising antimicrobial agents that are highly effective against serious bacterial infections.
Methods
In our previous study, a series of α-helical AMPs were screened using a novel multiple-descriptor strategy. The current research suggested that S24 exhibited strong antimicrobial activity against major pathogenic bacteria, and displayed minimal haemolysis, good serum stability and maintained salt resistance.
Results
We found that S24 exerted an antimicrobial effect by destroying outer membrane permeability and producing a strong binding effect on bacterial genomic DNA that inhibits genomic DNA migration. Furthermore, S24 exerted a strong ability to promote healing in wound infected by P. aeruginosa, A. baumannii and mixed strains in a mouse model.
Conclusions
Overall, S24 showed good stability under physiological conditions and excellent antimicrobial activity, suggesting it may be a potential candidate for the development of serious bacterial infection treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China.
- Weihuakang (Shenzhen) Biotech. Co., Ltd., Shenzhen 518001, China.
ORCID-Profile: Yi-Xuan Zhang
Förderung
- Science & Technology Fundamental Resources Investigation Program
- Liao Ning Revitalization Talents Program
- Basic Scientific Research Project of Colleges and University of Liaoning Provincial Department of Education
- Shenyang Pharmaceutical University
Zitieren
APA
Zhang, M. Y., Li, S., Wang, C. Y., Zhang, Z. X., Han, Y. L., Liu, X. Q., Cheng, J., Zhou, X. Y., & Zhang, Y. X. (2024). A novel antimicrobial peptide S24 combats serious wound infections caused by Pseudomonas aeruginosa and Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae191
Vancouver
Zhang MY, Li S, Wang CY, Zhang ZX, Han YL, Liu XQ, et al. A novel antimicrobial peptide S24 combats serious wound infections caused by Pseudomonas aeruginosa and Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae191
BibTeX
@article{Zhang2024,
author = {Zhang, Meng-Yue and Li, Shuang and Wang, Cai-Yun and Zhang, Zi-Xuan and Han, Yu-Ling and Liu, Xin-Qi and Cheng, Juan and Zhou, Xun-Yong and Zhang, Yi-Xuan},
title = {A novel antimicrobial peptide S24 combats serious wound infections caused by Pseudomonas aeruginosa and Acinetobacter baumannii},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
doi = {10.1093/jac/dkae191}
}
EUVIMED